These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 36672201)

  • 1. Preclinical Evaluation of a Novel Small Molecule LCC-21 to Suppress Colorectal Cancer Malignancy by Inhibiting Angiogenic and Metastatic Signatures.
    Mokgautsi N; Kuo YC; Huang YJ; Chen CH; Mukhopadhyay D; Wu ATH; Huang HS
    Cells; 2023 Jan; 12(2):. PubMed ID: 36672201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical Identification of Sulfasalazine's Therapeutic Potential for Suppressing Colorectal Cancer Stemness and Metastasis through Targeting KRAS/MMP7/CD44 Signaling.
    Leung WH; Shih JW; Chen JS; Mokgautsi N; Wei PL; Huang YJ
    Biomedicines; 2022 Feb; 10(2):. PubMed ID: 35203586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive Omics Analysis of a Novel Small-Molecule Inhibitor of Chemoresistant Oncogenic Signatures in Colorectal Cancer Cell with Antitumor Effects.
    Huang TH; Mokgautsi N; Huang YJ; Wu ATH; Huang HS
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical Repurposing of Sitagliptin as a Drug Candidate for Colorectal Cancer by Targeting
    Shih JW; Wu ATH; Mokgautsi N; Wei PL; Huang YJ
    Int J Mol Sci; 2024 Jan; 25(1):. PubMed ID: 38203779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of colorectal cancer metastasis markers by an angiogenesis-related cytokine-antibody array.
    Abajo A; Bitarte N; Zarate R; Boni V; Lopez I; Gonzalez-Huarriz M; Rodriguez J; Bandres E; Garcia-Foncillas J
    World J Gastroenterol; 2012 Feb; 18(7):637-45. PubMed ID: 22363134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical Evaluation of the Novel Small-Molecule MSI-N1014 for Treating Drug-Resistant Colon Cancer via the LGR5/β-catenin/miR-142-3p Network and Reducing Cancer-Associated Fibroblast Transformation.
    Yadav VK; Huang YJ; George TA; Wei PL; Sumitra MR; Ho CL; Chang TH; Wu ATH; Huang HS
    Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32560222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-148a suppressed cell invasion and migration via targeting WNT10b and modulating β-catenin signaling in cisplatin-resistant colorectal cancer cells.
    Shi L; Xi J; Xu X; Peng B; Zhang B
    Biomed Pharmacother; 2019 Jan; 109():902-909. PubMed ID: 30551544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gamma-mangostin isolated from garcinia mangostana suppresses colon carcinogenesis and stemness by downregulating the GSK3β/β-catenin/CDK6 cancer stem pathway.
    Wu AT; Yeh YC; Huang YJ; Mokgautsi N; Lawal B; Huang TH
    Phytomedicine; 2022 Jan; 95():153797. PubMed ID: 34802869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiomics Study of a Novel Naturally Derived Small Molecule, NSC772864, as a Potential Inhibitor of Proto-Oncogenes Regulating Cell Cycle Progression in Colorectal Cancer.
    Mokgautsi N; Kuo YC; Chen CH; Huang YJ; Wu ATH; Huang HS
    Cells; 2023 Jan; 12(2):. PubMed ID: 36672275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DHX32 Promotes Angiogenesis in Colorectal Cancer Through Augmenting β-catenin Signaling to Induce Expression of VEGFA.
    Lin H; Fang Z; Su Y; Li P; Wang J; Liao H; Hu Q; Ye C; Fang Y; Luo Q; Lin Z; Pan C; Wang F; Zhang ZY
    EBioMedicine; 2017 Apr; 18():62-72. PubMed ID: 28330603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Special AT-rich sequence-binding protein 2 acts as a negative regulator of stemness in colorectal cancer cells.
    Li Y; Liu YH; Hu YY; Chen L; Li JM
    World J Gastroenterol; 2016 Oct; 22(38):8528-8539. PubMed ID: 27784965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer.
    Hu JL; Wang W; Lan XL; Zeng ZC; Liang YS; Yan YR; Song FY; Wang FF; Zhu XH; Liao WJ; Liao WT; Ding YQ; Liang L
    Mol Cancer; 2019 May; 18(1):91. PubMed ID: 31064356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RHBDD1 promotes colorectal cancer metastasis through the Wnt signaling pathway and its downstream target ZEB1.
    Zhang M; Miao F; Huang R; Liu W; Zhao Y; Jiao T; Lu Y; Wu F; Wang X; Wang H; Zhao H; Ju H; Miao S; Wang L; Song W
    J Exp Clin Cancer Res; 2018 Feb; 37(1):22. PubMed ID: 29426364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACSL4 promotes colorectal cancer and is a potential therapeutic target of emodin.
    Dai G; Wang D; Ma S; Hong S; Ding K; Tan X; Ju W
    Phytomedicine; 2022 Jul; 102():154149. PubMed ID: 35567995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FUBP1 promotes colorectal cancer stemness and metastasis via DVL1-mediated activation of Wnt/β-catenin signaling.
    Yin H; Gao T; Xie J; Huang Z; Zhang X; Yang F; Qi W; Yang Z; Zhou T; Gao G; Yang X
    Mol Oncol; 2021 Dec; 15(12):3490-3512. PubMed ID: 34288405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the CRYAB gene on stem cell-like properties of colorectal cancer and its mechanism.
    Dai A; Guo X; Yang X; Li M; Fu Y; Sun Q
    J Cancer Res Ther; 2022 Sep; 18(5):1328-1337. PubMed ID: 36204880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P53-induced miR-1249 inhibits tumor growth, metastasis, and angiogenesis by targeting VEGFA and HMGA2.
    Chen X; Zeng K; Xu M; Liu X; Hu X; Xu T; He B; Pan Y; Sun H; Wang S
    Cell Death Dis; 2019 Feb; 10(2):131. PubMed ID: 30755600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor inhibiting HIF1α (FIH-1) functions as a tumor suppressor in human colorectal cancer by repressing HIF1α pathway.
    Chen T; Ren Z; Ye LC; Zhou PH; Xu JM; Shi Q; Yao LQ; Zhong YS
    Cancer Biol Ther; 2015; 16(2):244-52. PubMed ID: 25602156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sophocarpine Inhibits Tumorgenesis of Colorectal Cancer via Downregulation of MEK/ERK/VEGF Pathway.
    Wang Q; Wang T; Zhu L; He N; Duan C; Deng W; Zhang H; Zhang X
    Biol Pharm Bull; 2019 Nov; 42(11):1830-1838. PubMed ID: 31434836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytoplasmic SHMT2 drives the progression and metastasis of colorectal cancer by inhibiting β-catenin degradation.
    Liu C; Wang L; Liu X; Tan Y; Tao L; Xiao Y; Deng P; Wang H; Deng Q; Lin Y; Jie H; Zhang H; Zhang J; Peng Y; Zhang H; Zhou Z; Sun Q; Cen X; Zhao Y
    Theranostics; 2021; 11(6):2966-2986. PubMed ID: 33456583
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.